(Q47287444)

13 January 2018

title

Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females (English)

1 reference

13 January 2018

1 reference

S Bertelloni

1

1 reference

13 January 2018

G I Baroncelli

2

1 reference

13 January 2018

M C Sorrentino

3

1 reference

13 January 2018

G Perri

4

1 reference

13 January 2018

G Saggese

5

1 reference

13 January 2018

publication date

1 May 1998

1 reference

13 January 2018

European Journal of Pediatrics

published in

1 reference

13 January 2018

volume

157

1 reference

13 January 2018

issue

5

1 reference

13 January 2018

page(s)

363-367

1 reference

13 January 2018

https://scigraph.springernature.com/pub.10.1007/s004310050831

exact match

0 references

cites work

Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Estrogen status and heredity are major determinants of premenopausal bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Short-term effect of testosterone treatment on reduced bone density in boys with constitutional delay of puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Increases in bone density during treatment of men with idiopathic hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Effects of heredity, age, weight, puberty, activity, and calcium intake on bone mineral density in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Reversible trabecular bone density loss following induced hypo-oestrogenism with the GnRH analogue buserelin in premenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Bone mineral density during treatment of central precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Final height in central precocious puberty after long term treatment with a slow release GnRH agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Osteopenia in Men with a History of Delayed Puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Heritable and life-style determinants of bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Laboratory monitoring of children with precocious puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Attainment of peak bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Bone mass reduction after estrogen deprivation by long-acting gonadotropin-releasing hormone agonists and its relation to pretreatment serum concentrations of 1,25-dihydroxyvitamin D3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Reversible bone loss in women treated with GnRH-agonists for endometriosis and uterine leiomyoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS004310050831

Hormonal therapies for endometriosis: implications for bone metabolism

21 January 2018

1 reference

12 December 2020

Adult height in girls with idiopathic true precocious puberty

1 reference

12 December 2020

Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects

1 reference

12 December 2020

Clinical review 60: Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty

1 reference

12 December 2020

Factors that influence peak bone mass formation: a study of calcium balance and the inheritance of bone mass in adolescent females

1 reference

12 December 2020

Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty.

1 reference

12 December 2020

Effect of estrogen replacement therapy on bone mineral content in girls with Turner syndrome

1 reference

12 December 2020

Spinal and femoral bone mass accumulation during normal adolescence: comparison with female patients with sexual precocity and with hypogonadism.

1 reference

12 December 2020

1 reference

12 December 2020

Bone mass in endometriosis patients treated with GnRH agonist implant or danazol

1 reference

12 December 2020

Identifiers

DOI

10.1007/S004310050831

1 reference

13 January 2018

1 reference

13 January 2018